A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer
Phase 2 Completed
50 enrolled
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Phase 2 Completed
84 enrolled
FRAIL-IMMUNE
Phase 2 Completed
104 enrolled
OPERA
Phase 2 Completed
72 enrolled
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Phase 3 Completed
349 enrolled 29 charts
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
Phase 2 Completed
42 enrolled 14 charts
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Phase 2 Completed
47 enrolled
TICE
Phase 2 Completed
101 enrolled
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
Phase 3 Completed
371 enrolled 18 charts
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN
Phase 2 Completed
14 enrolled 17 charts
Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer
Phase 2 Completed
180 enrolled
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Phase 1 Completed
24 enrolled
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Phase 2 Completed
223 enrolled 10 charts
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
Phase 3 Completed
167 enrolled
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
21 enrolled
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
Phase 2 Completed
67 enrolled 10 charts
EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients
Phase 2 Completed
143 enrolled
Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire
Phase 2 Completed
100 enrolled
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
Phase 2 Completed